Pharmaceutical
FDA MedWatch Drug Alerts
- Audience: Consumer, Health Professional, Pulmonology March 14, 2025 — FDA advises consumers not to inhale nitrous oxide products from any size canisters, tanks, or chargers. These products are marketed as both unflavored and flavored nitrous oxide…
- Audience: Pharmacy, Health Care Professional March 13, 2025 — Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”), is…
- Audience: Consumer, Pharmacy March 11, 2025 — FDA is alerting the public and industry to the results of new agency testing of 95 acne products containing benzoyl peroxide for possible benzene contamination. FDA has concluded that a limited number…
- Audience: Patient, Health Professional, Pharmacy, Immunology March 10, 2025 — As a precautionary measure, the following lots of Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC) have been voluntarily withdrawn by the…
- Audience: Consumer Benton, Arkansas – 03/03/2025 –One Source Nutrition is voluntarily recalling all lots of Vitality capsules to the Consumer level. FDA analysis has found the product to be tainted with sildenafil and tadalafil, which…
New Drug Approvals
- Paris, March 28, 2025. The US Food and Drug Administration (FDA) has approved Qfitlia (fitusiran), the first antithrombin-lowering (AT) therapy for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric…
- On March 28, 2025, the Food and Drug Administration approved durvalumab (Imfinzi, AstraZeneca) with gemcitabine and cisplatin as neoadjuvant treatment, followed by single agent durvalumab as adjuvant treatment following radical cystectomy, for…
- Basel, March 28, 2025 – Novartis announced today that the US Food and Drug Administration (FDA) approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for patients with prostate-specific membrane antigen (PSMA)-positive metastatic…
- LAKE ZURICH, Ill., March 27, 2025 — Fresenius announced that the Biologics License Application (BLA) for the denosumab biosimilar Bomyntra (denosumab-bnht) of its operating company Fresenius Kabi has been approved by the U.S. Food and Drug…
- LAKE ZURICH, Ill., March 27, 2025 — Fresenius announced that the Biologics License Application (BLA) for the denosumab biosimilar Conexxence (denosumab-bnht) of its operating company Fresenius Kabi has been approved by the U.S. Food and Drug…
New Drug Applications
- MONTREAL and CHARLOTTE, N.C., March 28, 2025 (GLOBE NEWSWIRE) — Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding its New Drug…
- CAMBRIDGE, Mass.–(BUSINESS WIRE)–Mar. 25, 2025– Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for neuromuscular diseases, cardiometabolic disorders, and other serious diseases…
- Paris, March 25, 2025. The US Food and Drug Administration (FDA) is evaluating under priority review the regulatory submission of tolebrutinib to treat non-relapsing secondary progressive multiple sclerosis (nrSPMS) and to slow disability…
- SAN DIEGO, March 04, 2025 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced the U.S. Food and Drug…
- London, UK — 03 March 2025 — GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration (FDA) has accepted for review the Biologics License Application for the use of depemokimab in two indications. The proposed indications are…
Clinical Trial Results
- RAHWAY, N.J.–(BUSINESS WIRE) March 27, 2025 — Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the first data presentation from the pivotal 3475A-D77 Phase 3 trial, evaluating the subcutaneous…
- Paris, March 26, 2025. The US Food and Drug Administration has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection. The decision was based on the potential of the vaccine candidate to…
- CRANBURY, N.J., March 25, 2025 /PRNewswire/ — Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system…
- Guangdong, China and Bagsværd, Denmark, 24 March 2025 –The United Laboratories International Holdings Limited (TUL) and Novo Nordisk A/S (Novo Nordisk) today announced that Novo Nordisk and TUL’s wholly-owned subsidiary The United…
- Researchers at the National Institutes of Health (NIH) have developed eye drops that extend vision in animal models of a group of inherited diseases that lead to progressive vision loss in humans, known as retinitis pigmentosa. The eye drops contain…
Daily Med News
- SATURDAY, March 29, 2025 — A new formula made with natural citrus oil could help cancer patients find relief from dry mouth, a common and painful side effect of radiation treatments. The formula was created by researchers at the University of…
- FRIDAY, March 28, 2025 — With a new law, signed by Gov. Spencer Cox on March 27, Utah has become the first U.S. state to ban the addition of fluoride to public drinking water, The New York Times reported. The law will go into effect on May 7…
- FRIDAY, March 28, 2025 — A Michigan resident has died after receiving an organ transplant infected with rabies, state health officials said Wednesday. The patient got the transplant at an Ohio hospital in December and passed away the following…
- FRIDAY, March 28, 2025 — As a measles outbreak spreads across U.S., doctors are now seeing a new and unexpected danger: Children getting sick from taking too much vitamin A. At Covenant Children’s Hospital in Lubbock, Texas, several…
- FRIDAY, March 28, 2025 — The Trump administration will lay off 10,000 workers at the U.S. Department of Health and Human Services (HHS) as part of a major reorganization, officials announced Thursday. The changes reflect efforts to cut the size of…
News for Health Professionals
- FDA Approves Tremfya for Adults Patients with Active Crohn’s Disease In March, Johnson & Johnson announced the U.S. Food and Drug Administration (FDA) approval of Tremfya (guselkumab) for the treatment of adults with moderately to…
- FRIDAY, March 28, 2025 — Combination lipid-lowering therapy (LLT) is associated with a greater reduction in low-density lipoprotein cholesterol (LDL-C) compared with statin monotherapy, according to a study published online March 23 in the Mayo…
- FRIDAY, March 28, 2025 — A high proportion of women seem to undergo mammography screening every year, despite recommendations for biennial screening, according to a research letter published online March 25 in the Annals of Internal…
- FRIDAY, March 28, 2025 — For patients with chronic obstructive pulmonary disorder (COPD), long-term inhaled corticosteroid (ICS) treatment is associated with increased rates of adverse composite and specific individual outcomes, according to a…
- FRIDAY, March 28, 2025 — New mothers are encouraged to engage in two hours per week of exercise, according to a consensus guideline published online March 25 in the British Journal of Sports Medicine. Margie H. Davenport, Ph.D., from University of…
